Quetiapine
In clinical developmentAlso known as Seroquel, Quetiapina, QUEtiapine Fumarate, Quetiapinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
A Pragmatic Randomized Trial Comparing Antipsychotics in Lewy Body Disease
Effectiveness of Switching Antipsychotic Medications
Sequential Multiple Assignment Randomized Trial for Bipolar Depression
Quetiapine for Bipolar Disorder and Alcohol Dependence
Double-blind placebo-controlled trial of quetiapine in anorexia nervosa.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Sequential Multiple Assignment Randomized Trial for Bipolar Depression
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- Addiction biology1
- European eating disorders review : the journal of the Eating Disorders Association1
- Comer SD1
- Cooper ZD1
- Foltin RW1
- Haney M1
- Hart CL1
- Kaye W1
- Klabunde M1
- Powers PS1
- Health Sciences Center1
- New York State Psychiatric Institute and Department of Psychiatry1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials